GPT and metabolic dysfunction-associated steatotic liver disease: A non-invasive fibrosis scoring system was developed by measuring clinical and laboratory parameters to identify advanced fibrosis, including the aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, NAFLD fibrosis score (NFS) (14), AST: platelet ratio index (APRI) (15), Fibrosis-4 (FIB-4) (16), and pediatric NAFLD fibrosis index (PNFI) (17).